Skip to main content

Published locations for DURATION-8: Exenatide/dapagliflozin efficacy holds up at 1 year

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. DURATION-8: Exenatide/dapagliflozin efficacy holds up at 1 year

User login

  • Reset your password
  • /content/duration-8-exenatide/dapagliflozin-efficacy-holds-1-year
  • /familypracticenews/article/140937/diabetes/duration-8-exenatide/dapagliflozin-efficacy-holds-1-year
  • /internalmedicinenews/article/140937/diabetes/duration-8-exenatide/dapagliflozin-efficacy-holds-1
  • /clinicalendocrinologynews/article/140937/diabetes/duration-8-exenatide/dapagliflozin-efficacy-holds
  • /ecardiologynews/article/140937/diabetes/duration-8-exenatide/dapagliflozin-efficacy-holds-1-year
  • /cardiology/article/140937/diabetes/duration-8-exenatide/dapagliflozin-efficacy-holds-1-year
  • /endocrinology/article/140937/diabetes/duration-8-exenatide/dapagliflozin-efficacy-holds-1-year
  • /internalmedicine/article/140937/diabetes/duration-8-exenatide/dapagliflozin-efficacy-holds-1-year
  • /familymedicine/article/140937/diabetes/duration-8-exenatide/dapagliflozin-efficacy-holds-1-year
  • /type-2-diabetes-icymi/article/140937/diabetes/duration-8-exenatide/dapagliflozin-efficacy-holds-1